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Background: The aim of the present study was to estimate minimally important differences (MIDs) in EQ-5D and
SF-6D indices and to explore the responsiveness of EQ-5D and SF-6D indices in stroke.
Methods: We used observational longitudinal survey data of EQ-5D and SF-36 that were administered to stroke
patients at baseline and at 10 months. A range of MIDs for both indexes was estimated using anchor-based
approaches. The modified Rankin scale and the Barthel index were used as an anchor.
Results: The MID estimates for EQ-5D ranged from 0.08 to 0.12 and those for SF-6D ranged from 0.04 to 0.14 in
stroke patients. The MID values for these two utility measures differed in absolute magnitude, as the SF-6D index
has wider range that that of the EQ-5D index.
Conclusions: The MID values for these two utility measures differed in absolute magnitude, as the SF-6D index has
wider range that that of the EQ-5D index. These MID estimates may assist the interpretation of health related quality
of life assessments related to health care intervention in stroke patients.
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In 2010, the mortality rate due to stroke was 53.2 per
population of 100,000 in Korea, making it the most
common single disease responsible for death in Korea
[1]. Given that stroke is a major cause of disability, the
quality of life following stroke can be as imperative as
the duration of life after stroke. Health-related quality of
life (HRQoL) is a person’s actual or expected physical,
emotional and social well-being resulting from a medical
condition or its treatment [2]. The use of HRQoL instru-
ments has become increasingly common in stroke as-
sessments [3,4].
Although HRQoL is currently recognized as an im-
portant endpoint in clinical trials, the meaningfulness of
HRQoL scores may not be apparent to patients, clini-
cians or researchers [5]. Schünemann & Guyatt have
stipulated that a minimally important difference (MID)* Correspondence: kshgive@gmail.com
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unless otherwise stated.of any HRQoL measure as the “smallest difference in
score in the outcome of interest that informed patients
or informed proxies perceive as important, either benefi-
cial or harmful, and which would lead the patient or
clinician to consider a change in the management” [6].
Interpretation of scores is an important issue in the field
of HRQoL measurement, but there is no consensus re-
garding the most appropriate method for assessing the
ability of an instrument to capture meaningful differ-
ences [7]. The MIDs has been determined using both,
anchor-based and distribution-based methods. The
anchor-based method was an approach to find out
HRQoL score changes on minimal changes in clinical
measures, which are defined as anchors, across multiple
time points. Clinical measures can be objective indica-
tors or subjective assessments of a patient status [8]. Es-
timating the MID is a special case of examining
responsiveness to change [9] Responsiveness has been
defined as the ability to detect changes that are mean-
ingful or clinically important [10]. When a HRQoL in-
strument is more responsive, it has the advantage ofis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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important effects [11] and is able to capture changes
when those meaningfully occur. Distribution-based
methods makes it possible to compare change observed
for measures that have a different raw metric, and the
degree of deviation within the sample without reference
to an external standard and provide no direct informa-
tion about the MID [9,12]. The role of the distribution-
based approaches is identifying the minimum detectable
change (MDC), and the MDC cannot universally and re-
liably replace the MID [13,14]. Therefore, anchor-based
measures are the only way to estimate the MID directly
[9,13,14].
The EQ-5D [15] is a generic preference-based HRQoL
instrument that generates utility scores that are used for
economic evaluation in the calculation of quality-
adjusted life years (QALYs). A systematic review con-
cluded that the EQ-5D was the most frequently used
questionnaire in cost–utility studies including QALYs
[16]. Worldwide, the short form-36 version 2 (SF-36 v2)
is one of the most popular generic instrument to meas-
ure HRQoL beyond cost-utility studies. The SF-36 v2 is
a short-form health survey with 36 questions that yields
an eight-scale profile (PF, physical functioning; RP, role
physical; BP, bodily pain; GH, general health; VT, vitality;
SF, social functioning; RE, role emotional; MH, mental
health) of functional health and well-being, as well as
two psychometrically based summary measures of phys-
ical and mental health and a preference-based health
utility index [17].
The MIDs for the EQ-5D or SF-6D index in patients
with various diseases have been investigated [18-20], al-
though the value of these studies is limited by the small
sample sizes. To our knowledge, none of the studies that
have considered the responsiveness of HRQoL instru-
ments in community-based stroke patient field have esti-
mated MIDs. The purpose of this article was to estimate
MIDs for the EQ-5D and SF-6D indices and to explore




Subjects who had suffered first ever or recurrent stroke
and were aged 50 years or older were invited to partici-
pate in our research using the registry of disabled per-
sons in Gyeong-ju city. Subjects disabled due to brain
tumor, Parkinson disease or brain trauma were excluded
from the study. Interviewers were nurses working in the
community health center. Those nurses were trained for
4 hours before survey and then they visited the subject
residences (home or nursing home). The first survey was
performed from July 2008 until October 2008 and the
second survey was conducted from May 2009 until July2009. Both surveys used the same questionnaire includ-
ing demographic factors, clinical information, and qual-
ity of life information such as EQ-5D, and SF-36 v2.
This study was approved by the Institutional Review
Board of Dongguk University, Gyeongju Hospital (ap-
proval number: DUGH 10–35). All participants provided
written informed consent.
Measures
General and clinical characteristics, the Modified Rankin
Scale (MRS) and the Barthel ADL index (BI) were gath-
ered by trained interviewers who were registered nurses.
The EQ-5D and the SF-36 v2 were self-administered
with or without assistant. The EQ-5D is a generic
preference-based measure that health status describes in
terms of five dimensions: mobility, self-care, usual activ-
ities, pain discomfort and anxiety/depression. Each di-
mension has three levels, indicating no problems, some
or moderate problems and extreme problems [15]. The
EQ-5D index of health state was calculated using the
valuation set of the Korean population [21]. Therefore,
the possible range of EQ-5D scores was from −0.171 to
1.0, with 1.0 denoting full health (11111 state), and 0.0
denoting as bad as being dead. The SF-6D utility score
could be calculated using Brazier’s et al’s algorithm,
which was recommended by authors (model 10) [22].
The SF-6D consists of six dimensions (i.e., physical func-
tioning, role limitations, social functioning, pain, mental
health and vitality) and each dimension can be ranked in
terms of between four and six levels. The SF-6D index
was elicited from a preference-based algorithm, which
was developed by the standard gamble method for the
population of the United Kingdom [22] because a
Korean valuation set for SF-6D was not available. There-
fore, the possible range of the SF-6D is from 0.296–1.0.
The MRS is a measure of disability. The scale consists
of six grades from 0–5, with 0 corresponding to no
symptoms and 5 corresponding to severe disability [23].
The BI is a measure of the ability to perform basic activ-
ities associated with daily living. We used the Korean
version of BI [24]. This is based on Collin’s modified BI,
which ranges from 0–20 [25]. A higher BI score indi-
cates more independence in physical functioning. There
was evidence on validity and reliability of EQ-5D, SF-36
and BI in Korean population [26-29].
Analyses
We assessed the usefulness of anchors by investigating
the correlation between the changes of index scores and
the anchor-change score. Yost and Eton suggested that
the anchor change scores and HRQoL change scores
should be linearly related and have at least a moderate
correlation [5]. We used the change of MRS and BI to
determine anchor-based differences because it fulfilled
Table 1 General characteristics of study subjects at






80 and more 40 (8.2)




Proportion of reporting problems in EQ-5D
Mobility 430 (88.3)
Self-care 387 (79.5)











Mean (SD) 14.8 (6.0)
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anchor change scores and HRQoL change scores ranged
from 0.46 to 0.55). The change of MRS was arbitrarily
classified based on the movement between grades at
baseline and 10 months on the MRS: no change (no
movement), minimally better (improvement of l grade),
sizeable better (improvement of more than l level), min-
imally worse (deterioration of l grade), and sizeable
worse (deterioration of more than l level). As suggested
in previous publications, we considered a difference of at
least four points as a significant difference of scores in
case of BI [25]. Groups were classified based on the
range of changes in the BI score. Those classifications
were either: no change (change from −3 to 3 points),
minimally better (increase from 4 to 6 points), sizable
better (increase of more than 6 points), minimally worse
(decrease from 4 to 6 points), and sizable worse (de-
crease of more than 6 points).
We considered the mean score difference of both indi-
ces in ‘minimally better’ and ‘minimally worse’ categories
to be an adequate estimate of MID. The significance of
differences in mean score changes between any two time
points was tested using the Wilcoxon signed-rank test.
Responsiveness of both of the EQ-5D and the SF-6D
indices were compared using effect size (ES) and the
standardized response mean (SRM). ES was calculated
as the ratio between the mean change scores and the
standard deviation of baseline scores [30]. The SRM was
calculated as a ratio of mean change scores to the SD of
the change scores [31]. Both, effect size and SRM were
interpreted using benchmarks for effect size. Whereas
0.2 was interpreted as a small magnitude of effect, 0.5
indicated a medium effect and 0.8 was interpreted as a
large effect [32].
We excluded subjects who missed any items in either
EQ-5D or SF-6D. Subjects were additionally excluded in
either MRS-based or BI-based analysis if the MRS or BI
index were not completed at either time point, therefore
there were two different analysis sets.
Results
General characteristics
Of 991 potential subjects, 541 persons participated in
both interviews. Of the participants, 54 were excluded
from the analysis owing to missing answers for either
EQ-5D or SF-6D items in the SF-36 questionnaire. Thus,
the final analysis set consisted of 487 subjects. The mean
age of the subjects was 68.3 years (SD 8.1) and 58.9%
were men. Regarding MRS scores for subjects at base-
line, 1% had no symptoms, 11.5% had no significant
symptoms, 31.1% presented with slight disability, 32.5%
presented with moderate disability, 15.6% presented with
moderately severe disability and 7.8% presented with se-
vere disability (Table 1). First ever stroke counted for332 (69.8%) and years since first stroke occurred
counted for 9.0 (SD 7.3).
Anchor-based approach
The mean changes, SRM and ES in the EQ-5D and SF-
6D indices according to categories of change in MRS
and BI are listed in Table 2. Most subjects who im-
proved or deteriorated showed significant changes in the
scores of both, the EQ-5D and SF-6D indices. for the
EQ-5D using MRS as the basis for the anchor-based
method ranged from 0.08 (as seen in the minimal im-
provement group to 0.12 (as seen in the minimal deteri-
oration group) The estimated MID for the SF-6D index
using the MRS as the basis for the anchor-based method
ranged from 0.04 (as seen in the minimal deterioration
group) to 0.07 (as seen in the minimal improvement
group). The estimated MID using the BI as the basis for
the anchor-based method ranged from 0.09 at minimal
improvement to 0.12 at minimal deterioration for the
EQ-5D index, whereas it ranged from 0.04 at minimal
deterioration to 0.14 at minimal improvement for the
SF-6D index. The magnitude and pattern in SRM and
Table 2 Anchor-based approach for determining minimally important differences for the EQ-5D and SF-6D indices
Modified rankin Scale based Barthel ADL index based
N Mean change (SD)
(time2-time1)




All 484 −0.04 (0.27) 0.003 0.15 0.07 442 −0.05 (0.26) 0.001 0.17 0.08
Sizeable better 17 0.17 (0.26) 0.015 0.66 0.71 23 0.23 (0.31) <0.001 0.76 0.72
Minimally better 86 0.08* (0.21) <0.001 0.38 0.28 27 0.09* (0.28) 0.048 0.32 0.31
No change 220 −0.01 (0.22) 0.413 0.06 0.03 281 −0.01 (0.19) 0.471 0.06 0.03
Minimally worse 115 −0.12* (0.26) <0.001 0.47 0.46 53 −0.12* (0.23) <0.001 0.50 0.43
Sizeable worse 46 −0.27 (0.26) <0.001 0.75 0.84 58 −0.33 (0.34) <0.001 0.97 1.27
P-value§ <0.001 <0.001
SF-6D index
All 484 0.01 (0.14) 0.520 0.04 0.01 442 0.01 0.14 0.334 0.05 0.01
Sizeable better 19 0.16 (0.13) 0.002 1.21 1.33 23 0.14 (0.12) <0.001 1.17 1.40
Minimally better 86 0.07* (0.13) <0.001 0.52 0.58 27 0.14* (0.15) <0.001 0.92 1.11
No change 220 0.01 (0.13) 0.296 0.07 0.08 281 0.01 (0.14) 0.373 0.05 0.08
Minimally worse 115 −0.04* (0.12) <0.001 0.33 0.36 53 −0.04* (0.13) 0.068 0.27 0.33
Sizeable worse 46 −0.08 (0.12) <0.001 0.50 0.53 58 −0.06 (0.12) <.0001 0.53 0.55
P-value§ <0.001 <0.001
SRM = standardized response mean; ES = effect size.
*These scores are estimates of the MID.
†P-value by Wilcoxon signed rank test.
§P-value by Kruskal Wallis test.
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MRS-anchored responsiveness. The SRM and ES for
both, the EQ-5D index and SF-6D index were of similar
magnitude and pattern using the MRS and BI anchored
approaches. For patients in the sizable better and min-
imally better categories, the EQ-5D was less responsive
than SF-6D, whereas for patients classified as being ei-
ther sizable worse or minimally worse, the EQ-5D was
more responsive than SF-6D.
Discussion
This study estimated MIDs using anchor -based
methods in stroke patients of a community-based co-
hort. This study showed that the MID estimates for EQ-
5D ranged from 0.08–0.12 whereas the MID estimates
for SF-6D ranged from 0.04–0.14. The distribution- and
anchor-based estimates tended to converge. The MID
may change depending on the anchor used, the defin-
ition of ‘important change’ for that anchor, the type of
anchor, the baseline values and the direction of change
[14,18]. We used the change of MRS and BI as an an-
chor. Both scales have an acceptable degree of reliability
in stroke [33]. The relationship was a linear positive cor-
relation between the score changes for both indices with
the categories of MRS and BI. We thus selected them as
anchors. We found that stroke patients who reported
global worsening had considerably larger score changeson the EQ-5D index than those reporting comparable
global improvement in MRS anchored group (p = 0.032).
On the other hand, stroke patients who reported global
improvement had considerably larger score changes on
the SF-6D index than those reporting comparable global
worsening in BI anchored group (p = 0.045). In other
words, the MID for the EQ-5D and SF-6D indices is
likely to differ according to the direction of change or
anchor used. We therefore displayed a range of MID
values to account for this diversity.
A study reviewing eight longitudinal studies in eleven
patient groups, using both, EQ-5D and SF-36, reported
that the mean MID for the EQ-5D index was 0.074 (ran-
ging from −0.011 to 0.140), and the mean MID for the
SF-6D index was 0.041 (ranging from 0.011 to 0.097)
[18]. Pickard et al. reported that MID estimate for the
EQ-5D ranged from 0.10–0.14 in cancer patients based
on performance status [7]. When calculating MID based
on distribution in a previously published study, MID es-
timates ranged from 0.11–0.19 for the EQ-5D index and
the corresponding estimates of the SF-6D index ranged
from 0.03–0.08 [19].
Given that the range of the EQ-5D index (−0.171 to
1.0) was wider than that of the SF-6D index (0.296 to
1.00), the SD of the EQ-5D index was generally higher
than that of the SF-6D index. The estimates of MID for
the EQ-5D were approximately twice those of MID for
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6D for patients with a minimally better state. Neverthe-
less, the MID estimates for each index seem to be
equivalent, considering the range of index scores for
each instrument.
This study also evaluated the responsiveness of the
EQ-5D and SF-6D indices. Our findings suggest that
both, the EQ-5D index and the SF-6D index were able
to show changes of health state (i.e., both, improvement
and deterioration) in stroke patients over the course of a
10-months period. The corresponding SRMs and ESs for
EQ-5D of patients with a minimal changing state ranged
from 0.27–0.50, and those for SF-6D of patients with a
minimal changing state ranged from 0.27–1.11. Most of
these values mainly indicated a small-to-medium effect
based on Cohen’s criteria [32]. Findings of responsive-
ness of the EQ-5D and SF-6D in stroke in our study
were consistent with the results of Pickard et al. [19].
However, EQ-5D and SF-6D was not equally responsive
to change in other disease group such as cataract and
heart failure patients [34,35] Researchers should be cau-
tious the MID estimates and consider domains of
preference-based measures may not detect the change
according to disease characteristics.
There are several limitations of our study. The assess-
ment on different time points was performed by differ-
ent interviewers and we did not evaluate the inter-rater
reliability in this study. However, there is evidence that
the BI is highly reliable when recorded by nurses [36].
Thus, even though different interviewers assessed MRS
and BI on the same person at different time points, the
variability should be less due to the qualification and
training course of the interviewers before survey. We ar-
bitrarily defined ‘important change’ as the change of one
grade on MRS and a change of 3–6 points in the BI
score. A validation study would be required for the usage
of both, MRS and BI as anchor. Sample size of BI
anchored- minimally better group was small, therefore
the estimated of the MID could be unstable. The MID
estimates for SF-6D may be of limited value for the as-
sessment in a Korean population, because we used an al-
gorithm based on populations in the United Kingdom.
However, MID estimates for EQ-5D using the Korean al-
gorithm in our study were similar to the results of other
researches using algorithms based on populations in the
United Kingdom and the United States of America [7].
Conclusion
The MIDs for these two utility measures slightly differed
in their absolute magnitudes and by direction of change.
Those MID estimates may be valuable for the interpret-
ation of intervention effects related to HRQoL, particu-
lar in stroke patients and for the calculation of sample
sizes for research studies.Abbreviations
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